Inventor · disambiguated record
Xianqi Kong
Also filed as: GORINE BORIS · KONG XIANQI
39 granted patents·47 pending applications·456 citations·filing 1995–2025
98Inventor score
Files withRISEN SUZHOU PHARMA TECH CO LTD31KONG XIANQI14NEUROCHEM INT LTD10UNIV KINGSTON6BELLUS HEALTH INC5
Top patents by PatentIndex Score
86 records- 0194US8748656B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidKONG XIANQI·Filed 2007·Granted Jun 10, 2014·17 cites·14 claims
- 0294US6562836B1Methods and compounds for inhibiting amyloid depositsUNIV KINGSTON·Filed 2000·Granted May 13, 2003·62 cites·172 claims
- 0392US11970490B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Apr 30, 2024·4 cites·24 claims
- 0491US9499480B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBHI LTD PARTNERSHIP·Filed 2014·Granted Nov 22, 2016·10 cites·13 claims
- 0590US10857109B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2019·Granted Dec 8, 2020·3 cites·11 claims
- 0689US11608314B2Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Mar 21, 2023·2 cites·16 claims
- 0789US11225497B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Jan 18, 2022·2 cites·16 claims
- 0889US10954188B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Mar 23, 2021·4 cites·17 claims
- 0989US10238611B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBHI LP·Filed 2016·Granted Mar 26, 2019·6 cites·9 claims
- 1089US7598269B2Methods and compositions for treating amyloid-related diseasesBELLUS HEALTH INT LTD·Filed 2007·Granted Oct 6, 2009·14 cites·14 claims
- 1189US7414076B2Methods and compositions for treating amyloid-related diseasesNEUROCHEM INT LTD·Filed 2004·Granted Aug 19, 2008·24 cites·32 claims
- 1289US7253306B2Pharmaceutical drug candidates and methods for preparation thereofNEUROCHEM INT LTD·Filed 2004·Granted Aug 7, 2007·33 cites·17 claims
- 1389US7244764B2Methods and compositions for treating amyloid-related diseasesNEUROCHEM INT LTD·Filed 2004·Granted Jul 17, 2007·29 cites·50 claims
- 1488US8642801B2Methods and compositions for treating amyloid-related diseasesKONG XIANQI·Filed 2009·Granted Feb 4, 2014·11 cites·17 claims
- 1586US8835654B2Method and compositions for treating amyloid-related diseasesKONG XIANQI·Filed 2011·Granted Sep 16, 2014·9 cites·6 claims
- 1686US8044100B2Methods and compositions for treating amyloid-related diseasesBELLUS HEALTH INC·Filed 2005·Granted Oct 25, 2011·9 cites·11 claims
- 1786US6440952B2Phosphono-carboxylate compounds for treating amyloidosisUNIV KINGSTON·Filed 2001·Granted Aug 27, 2002·20 cites·20 claims
- 1885US12459888B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Granted Nov 4, 2025·0 cites·3 claims
- 1985US10472323B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2017·Granted Nov 12, 2019·5 cites·20 claims
- 2085US2024065990A1Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2023·Application pending·0 cites
- 2184US11186543B2Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Nov 30, 2021·2 cites·24 claims
- 2284US11020360B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2020·Granted Jun 1, 2021·1 cites·8 claims
- 2384US7262223B2Amidine derivatives for treating amyloidosisNEUROCHEM INT LTD·Filed 2004·Granted Aug 28, 2007·18 cites·7 claims
- 2484US5858326AMethods of increasing amyloid depositionNEUROCHEM INC·Filed 1995·Granted Jan 12, 1999·79 cites·5 claims
- 2584US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 2682US11530234B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2020·Granted Dec 20, 2022·1 cites·21 claims
- 2779US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 2879US7393875B2Methods and compounds for inhibiting amyloid depositsNEUROCHEM INT LTD·Filed 2003·Granted Jul 1, 2008·9 cites·9 claims
- 2979US7311893B2Amyloid targeting imaging agents and uses thereofNEUROCHEM INT LTD·Filed 2003·Granted Dec 25, 2007·11 cites·38 claims
- 3077US5869469APhosphonocarboxylate compounds for treating amyloidosisUNIV KINGSTON·Filed 1997·Granted Feb 9, 1999·48 cites·25 claims
- 3177US2023295079A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2022·Application pending·0 cites
- 3276US10881681B2CD73 inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2019·Granted Jan 5, 2021·2 cites·21 claims
- 3375US11725020B2Prodrugs of a CDK inhibitor for treating cancersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Aug 15, 2023·0 cites·20 claims
- 3474US2021386693A1Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2021·Application pending·0 cites
- 3573US7786174B2Methods and compounds for inhibiting amyloid depositsBELLUS HEALTH INT LTD·Filed 2008·Granted Aug 31, 2010·1 cites·9 claims
- 3671US2008004244A1Phosphono-carboxylate compounds for treating amyloidosisNEUROCHEM INT LTD·Filed 2007·Application pending·0 cites
- 3771US2025352516A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 3869US2025109100A1Crystalline form of 3- ((l-valyl) amino) -i-propanesulfonic acidRISEN SUZHOU PHARMA TECH CO LTD·Filed 2024·Application pending·0 cites
- 3969US2025170161A1Inhibin subunit beta e inhibitor and methods of use thereofRISEN SHANGHAI MEDICINAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 4069US2021347731A1Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 4168US12365675B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 4268US9051248B2Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acidKONG XIANQI·Filed 2010·Granted Jun 9, 2015·1 cites·21 claims
- 4366US12403129B2Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular diseaseRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Sep 2, 2025·0 cites·2 claims
- 4466US6329356B1Phosphono-carboxylate compounds for treating amyloidosisNEUROCHEM INC·Filed 1999·Granted Dec 11, 2001·19 cites·31 claims
- 4564US2006135479A1Phosphono-carboxylate compounds for treating amyloidosisSZAREK WALTER A·Filed 2005·Application pending·0 cites
- 4663US2010190753A1Methods and Compositions for Treating Amyloid-Related DiseasesBELLUS HEALTH INT LTD·Filed 2009·Application pending·0 cites
- 4762US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
- 4862US2024246963A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 4961US2024050577A1Cdk inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 5061US2009099100A1Compositions and methods for treating amyloidosisBELLUS HEALTH INT LTD·Filed 2008·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xianqi Kong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →